Citations (612)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (29)
Atif Ahmed, Muhammad Safdar, Samran Sardar, Sahar Yousaf, Fiza Farooq, Ali Raza, Muhammad Shahid, Kausar Malik & Samia Afzal. (2022) Modern vaccine strategies for emerging zoonotic viruses. Expert Review of Vaccines 21:12, pages 1711-1725.
Read now
Read now
Md Kamal Hossain, Majid Hassanzadeganroudsari, Jack Feehan & Vasso Apostolopoulos. (2022) The race for a COVID-19 vaccine: where are we up to?. Expert Review of Vaccines 21:3, pages 355-376.
Read now
Read now
Gaurav Joshi, Pobitra Borah, Shweta Thakur, Praveen Sharma, Mayank & Ramarao Poduri. (2021) Exploring the COVID-19 vaccine candidates against SARS-CoV-2 and its variants: where do we stand and where do we go?. Human Vaccines & Immunotherapeutics 17:12, pages 4714-4740.
Read now
Read now
Mark Verdecia, John F. Kokai-Kun, Maura Kibbey, Sarita Acharya, Jaap Venema & Fouad Atouf. (2021) COVID-19 vaccine platforms: Delivering on a promise?. Human Vaccines & Immunotherapeutics 17:9, pages 2873-2893.
Read now
Read now
Christopher P. Karch & Gary R. Matyas. (2021) The current and future role of nanovaccines in HIV-1 vaccine development. Expert Review of Vaccines 20:8, pages 935-944.
Read now
Read now
Gautam Shenoy. (2020) When Little Things Make a Big Difference. Immunological Investigations 49:7, pages 692-697.
Read now
Read now
Xinnuo Lei, Xiong Cai & Yi Yang. (2020) Genetic engineering strategies for construction of multivalent chimeric VLPs vaccines. Expert Review of Vaccines 19:3, pages 235-246.
Read now
Read now
Laurent Durous, Manuel Rosa-Calatrava & Emma Petiot. (2019) Advances in influenza virus-like particles bioprocesses. Expert Review of Vaccines 18:12, pages 1285-1300.
Read now
Read now
Claudia Maria Trombetta, Serena Marchi, Ilaria Manini, Giacomo Lazzeri & Emanuele Montomoli. (2019) Challenges in the development of egg-independent vaccines for influenza. Expert Review of Vaccines 18:7, pages 737-750.
Read now
Read now
Wei Zhang, Wenlong Dai, Chao Zhang, Yu Zhou, Pei Xiong, Shuxia Wang, Xiaohua Ye, Qingwei Liu, Dongming Zhou & Zhong Huang. (2018) A virus-like particle-based tetravalent vaccine for hand, foot, and mouth disease elicits broad and balanced protective immunity. Emerging Microbes & Infections 7:1, pages 1-12.
Read now
Read now
Chao Zhang, Xueyang Zhang, Wei Zhang, Wenlong Dai, Jing Xie, Liping Ye, Hongli Wang, Huan Chen, Qingwei Liu, Sitang Gong, Lanlan Geng & Zhong Huang. (2018) Enterovirus D68 virus-like particles expressed in Pichia pastoris potently induce neutralizing antibody responses and confer protection against lethal viral infection in mice. Emerging Microbes & Infections 7:1, pages 1-22.
Read now
Read now
Volker Vetter, Gülhan Denizer, Leonard R. Friedland, Jyothsna Krishnan & Marla Shapiro. (2018) Understanding modern-day vaccines: what you need to know. Annals of Medicine 50:2, pages 110-120.
Read now
Read now
Yee Huang, Tao Qin, Yifan Huang, Zhenguang Liu, Ruonan Bo, Yuanliang Hu, Jiaguo Liu, Yi Wu & Deyun Wang. (2016) Rehmannia glutinosa polysaccharide liposome as a novel strategy for stimulating an efficient immune response and their effects on dendritic cells. International Journal of Nanomedicine 11, pages 6795-6808.
Read now
Read now
Peng Mi, Pengfei Zhang & Gang Liu. (2016) Bio-inspired virus-like nanovesicle for effective vaccination. Human Vaccines & Immunotherapeutics 12:8, pages 2090-2091.
Read now
Read now
S. Umar, S. Sarfraz, A. Mushtaq & M. Attique. (2016) RETRACTED ARTICLE: Emerging threat of H9N2 viruses in poultry of Pakistan and vaccination strategy. World's Poultry Science Journal 72:2, pages 343-352.
Read now
Read now
Man Wang, Shuai Jiang & Yefu Wang. (2016) Recent advances in the production of recombinant subunit vaccines in Pichia pastoris. Bioengineered 7:3, pages 155-165.
Read now
Read now
Vesna Blazevic, Maria Malm, Daisuke Arinobu, Suvi Lappalainen & Timo Vesikari. (2016) Rotavirus capsid VP6 protein acts as an adjuvant in vivo for norovirus virus-like particles in a combination vaccine. Human Vaccines & Immunotherapeutics 12:3, pages 740-748.
Read now
Read now
Yimei Jia, Lakshmi Krishnan & Abdelwahab Omri. (2015) Nasal and pulmonary vaccine delivery using particulate carriers. Expert Opinion on Drug Delivery 12:6, pages 993-1008.
Read now
Read now
Hongjing Gu, Tieling Li, Lina Han, Ping Zhu, Peirui Zhang, Shaogeng Zhang, Sujing Sun, Yueqiang Duan, Li Xing, Zhongpeng Zhao, Chengcai Lai, Bohai Wen, Xiliang Wang & PengHui Yang. (2015) Protection conferred by virus-like particle vaccines against respiratory syncytial virus infection in mice by intranasal vaccination . Human Vaccines & Immunotherapeutics 11:4, pages 1057-1064.
Read now
Read now
Shih-Yeh Lin, Yao-Chi Chung & Yu-Chen Hu. (2014) Update on baculovirus as an expression and/or delivery vehicle for vaccine antigens. Expert Review of Vaccines 13:12, pages 1501-1521.
Read now
Read now
Sita Awasthi, Carolyn Shaw & Harvey Friedman. (2014) Improving immunogenicity and efficacy of vaccines for genital herpes containing herpes simplex virus glycoprotein D. Expert Review of Vaccines 13:12, pages 1475-1488.
Read now
Read now
Yu-An Kung, Chuan-Tien Hung, Yen-Chin Liu & Shin-Ru Shih. (2014) Update on the development of enterovirus 71 vaccines. Expert Opinion on Biological Therapy 14:10, pages 1455-1464.
Read now
Read now
Ala-Eddin Al Moustafa, Rana Al-Awadhi, Nabiha Missaoui, Ishag Adam, Raika Durusoy, Lina Ghabreau, Nizar Akil, Hussain Gadelkarim Ahmed, Amber Yasmeen & Ghazi Alsbeih. (2014) Human papillomaviruses-related cancers. Human Vaccines & Immunotherapeutics 10:7, pages 1812-1821.
Read now
Read now
Manpreet Kaur, Samer Singh & Rakesh Bhatnagar. (2013) Anthrax vaccines: present status and future prospects. Expert Review of Vaccines 12:8, pages 955-970.
Read now
Read now
Joshua W Wang & Richard BS Roden. (2013) Virus-like particles for the prevention of human papillomavirus-associated malignancies. Expert Review of Vaccines 12:2, pages 129-141.
Read now
Read now
Qiang Chen & Huafang Lai. (2013) Plant-derived virus-like particles as vaccines. Human Vaccines & Immunotherapeutics 9:1, pages 26-49.
Read now
Read now
Pele Chong, Shih-Yang Hsieh, Chia-Chyi Liu, Ai-Hsiang Chou, Jui-Yuan Chang, Suh-Chin Wu, Shih-Jen Liu, Yen-Hung Chow, Ih-Jen Su & Michel Klein. (2012) Production of EV71 vaccine candidates. Human Vaccines & Immunotherapeutics 8:12, pages 1775-1783.
Read now
Read now
Wei Shao, Arghya Paul, Sana Abbasi, Parminder S Chahal, Jimmy A Mena, Johnny Montes, Amine Kamen & Satya Prakash. (2012) A novel polyethyleneimine-coated adeno-associated virus-like particle formulation for efficient siRNA delivery in breast cancer therapy: preparation and in vitro analysis. International Journal of Nanomedicine 7, pages 1575-1586.
Read now
Read now
Zhaojun Yin & Xuefei Huang. (2012) Recent Development in Carbohydrate Based Anticancer Vaccines. Journal of Carbohydrate Chemistry 31:3, pages 143-186.
Read now
Read now
Articles from other publishers (583)
Luis A. Rojas & Vinod P. Balachandran. 2024. Clinical Immuno-Oncology. Clinical Immuno-Oncology
177
194.e3
.
Chia-Chun Chang, Ching-Ying Wu, Jhao-Guan Ciou, Ching-Wei Wu, Yi-Chen Wang, Hui-Wen Chang, Maw-Sheng Chien & Chienjin Huang. (2023) Exploring the surface epitope and nuclear localization analysis of porcine circovirus type 3 capsid protein. AMB Express 13:1.
Crossref
Crossref
Valentina Ganeva & Andreas Kranz. (2023) Selective extraction of recombinant membrane proteins from Hansenula polymorpha by pulsed electric field and lytic enzyme pretreatment. Microbial Cell Factories 22:1.
Crossref
Crossref
Yu-Ling Chen, Chun-Jie Bao, Jia-Lun Duan, Ying Xie & Wan-Liang Lu. (2023) Overcoming biological barriers by virus-like drug particles for drug delivery. Advanced Drug Delivery Reviews 203, pages 115134.
Crossref
Crossref
Stefanie K. Menzies, Raquel Arinto-Garcia, Fernanda Gobbi Amorim, Iara Aimê Cardoso, Camille Abada, Thomas Crasset, Fabien Durbesson, Rebecca J. Edge, Priscila El-Kazzi, Sophie Hall, Damien Redureau, Richard Stenner, Johara Boldrini-França, Huan Sun, António Roldão, Paula M. Alves, Robert A. Harrison, Renaud Vincentelli, Imre Berger, Loïc Quinton, Nicholas R. Casewell & Christiane Schaffitzel. (2023) ADDovenom: Thermostable Protein-Based ADDomer Nanoparticles as New Therapeutics for Snakebite Envenoming. Toxins 15:12, pages 673.
Crossref
Crossref
Chenghai Bai, Chen Wang & Yuan Lu. (2023) Novel Vectors and Administrations for mRNA Delivery. Small 19:46.
Crossref
Crossref
Elmas Pınar KAHRAMAN KILBAŞ & Mustafa ALTINDİŞ. (2023) Mevcut ve Gelişmekte Olan Aşı Teknolojileri; Kısa derlemeCurrent and Emerging Vaccine Technologies; A short review. Journal of Biotechnology and Strategic Health Research 7:3, pages 148-156.
Crossref
Crossref
Rocio Mellid-Carballal, Sara Gutierrez-Gutierrez, Carmen Rivas & Marcos Garcia-Fuentes. (2023) Viral protein-based nanoparticles (part 2): Pharmaceutical applications. European Journal of Pharmaceutical Sciences 189, pages 106558.
Crossref
Crossref
Büşra Ahata & Günseli Bayram Akçapınar. (2023) CCHFV vaccine development, current challenges, limitations, and future directions. Frontiers in Immunology 14.
Crossref
Crossref
Chittaranjan Baruah, Pankaj Das, Papari Devi, Palash Moni Saikia & Bhabesh Deka. (2023) The emergence of nanovaccines as a new paradigm in virological vaccinology: a review. Exploration of Immunology, pages 361-383.
Crossref
Crossref
Yongping Yang, Wing-Pui Kong, Cuiping Liu, Tracy J. Ruckwardt, Yaroslav Tsybovsky, Lingshu Wang, Shuishu Wang, Daniel W. Biner, Man Chen, Tracy Liu, Jonah Merriam, Adam S. Olia, Li Ou, Qi Qiu, Wei Shi, Tyler Stephens, Eun Sung Yang, Baoshan Zhang, Yi Zhang, Qiong Zhou, Reda Rawi, Richard A. Koup, John R. Mascola & Peter D. Kwong. (2023) Enhancing Anti-SARS-CoV-2 Neutralizing Immunity by Genetic Delivery of Enveloped Virus-like Particles Displaying SARS-CoV-2 Spikes. Vaccines 11:9, pages 1438.
Crossref
Crossref
Aleksandra Anna Zasada, Aniela Darlińska, Aldona Wiatrzyk, Katarzyna Woźnica, Kamila Formińska, Urszula Czajka, Małgorzata Główka, Klaudia Lis & Paulina Górska. (2023) COVID-19 Vaccines over Three Years after the Outbreak of the COVID-19 Epidemic. Viruses 15:9, pages 1786.
Crossref
Crossref
Zhaoming Li, Kaimin Song, Yongzhen Du, Zhuanglong Zhang, Rupeng Fan, Pimiao Zheng & Jianzhu Liu. (2023) Diagnosis of a Rabbit Hemorrhagic Disease Virus 2 (RHDV2) and the Humoral Immune Protection Effect of VP60 Vaccine. Current Issues in Molecular Biology 45:8, pages 6605-6617.
Crossref
Crossref
Zejie Chang, Yongkun Du, Ruiqi Li, Xueke Sun, Yilan Chen, Minghui Li, Lu Fan, Siyuan Liu, Siqiao Wang, Peiyang Ding & Gaiping Zhang. (2023) Development and characterization of monoclonal antibody against the critical loop structure of african swine fever virus P72 protein. Veterinary Microbiology 283, pages 109776.
Crossref
Crossref
Janna R. Shapiro, Guadalupe Andreani, Charlotte Dubé, Mélanie Berubé, Diane Bussière, Manon M.-J. Couture, Michèle Dargis, Hilary E. Hendin, Nathalie Landry, Pierre-Olivier Lavoie, Stéphane Pillet, Brian J. Ward, Marc-André D'Aoust & Sonia Trépanier. (2023) Development and characterization of a plant-derived norovirus-like particle vaccine. Vaccine.
Crossref
Crossref
Parisa Hashemi, Shirin Mahmoodi & Abdolmajid Ghasemian. (2023) An updated review on oral protein-based antigen vaccines efficiency and delivery approaches: a special attention to infectious diseases. Archives of Microbiology 205:8.
Crossref
Crossref
Youhuai Li, Mina Wang, Xueqiang Peng, Yingying Yang, Qishuang Chen, Jiaxing Liu, Qing She, Jichao Tan, Chuyuan Lou, Zehuan Liao & Xuexin Li. (2023) mRNA vaccine in cancer therapy: Current advance and future outlook. Clinical and Translational Medicine 13:8.
Crossref
Crossref
Félix Lamontagne, Dominic Arpin, Mélanie Côté‐Cyr, Vinay Khatri, Philippe St‐Louis, Laurie Gauthier, Denis Archambault & Steve Bourgault. (2023) Engineered Curli Nanofilaments as a Self‐Adjuvanted Antigen Delivery Platform. Advanced Healthcare Materials 12:21.
Crossref
Crossref
Hang Zhang, Qin Luo, Yingxin He, Yajie Zheng, Huiyang Sha, Gan Li, Weili Kong, Jiedan Liao & Mengmeng Zhao. (2023) Research Progress on the Development of Porcine Reproductive and Respiratory Syndrome Vaccines. Veterinary Sciences 10:8, pages 491.
Crossref
Crossref
Jorge João & Duarte Miguel F. Prazeres. (2023) Manufacturing of non-viral protein nanocages for biotechnological and biomedical applications. Frontiers in Bioengineering and Biotechnology 11.
Crossref
Crossref
Jaekeun Park, Chang-Seon Song, David Hyunjung Chung, Sangyong Choi, Junghoon Kwon, Sungsu Youk & Dong-Hun Lee. (2023) Chimeric H5 influenza virus-like particle vaccine elicits broader cross-clade antibody responses in chickens than in ducks. Frontiers in Veterinary Science 10.
Crossref
Crossref
Renata Gois de Mello, Thaissa Consoni Bernardino, Luis Giovani Oliveira Guardalini, Renato Mancini Astray, Marta Maria Antoniazzi, Simone Gonçalves Silva Jared, Eutimio Gustavo Fernández Núñez & Soraia Attie Calil Jorge. (2023) Zika virus-like particles (VLPs) produced in insect cells. Frontiers in Pharmacology 14.
Crossref
Crossref
Salma Bricha, Mélanie Côté-Cyr, Thomas Tremblay, Phuong Trang Nguyen, Philippe St-Louis, Denis Giguère, Denis Archambault & Steve Bourgault. (2023) Synthetic Multicomponent Nanovaccines Based on the Molecular Co-assembly of β-Peptides Protect against Influenza A Virus. ACS Infectious Diseases 9:6, pages 1232-1244.
Crossref
Crossref
Rama Sharma. (2023) Nanomaterials as Theragnostic Tools of Detection and Fighting off the Virus. Nanoscience & Nanotechnology-Asia 13:3.
Crossref
Crossref
Tiana Loan Young, Kevin Chang Wang, Andrew James Varley & Bowen Li. (2023) Clinical delivery of circular RNA: Lessons learned from RNA drug development. Advanced Drug Delivery Reviews 197, pages 114826.
Crossref
Crossref
Keman Cheng, Nana Ma, Jie Liang, Xiaotu Ma, Qingqing Feng, Guangna Liu, Chen Xu, Ming Tang, Lizhuo Zhang, Xiaoyu Gao, Jiaqi Xu, Chufan Wang, Fei Zhu, Xinwei Wang, Xiang Li, Xiao Zhao & Guangjun Nie. (2023) Site‐Specific Modification of Virus‐Like Particles for Exogenous Tumor Antigen Display and Minimizing Preexisting Immunity. Small 19:23.
Crossref
Crossref
Annalaura Brai, Federica Poggialini, Claudia Pasqualini, Claudia Immacolata Trivisani, Chiara Vagaggini & Elena Dreassi. (2023) Progress towards Adjuvant Development: Focus on Antiviral Therapy. International Journal of Molecular Sciences 24:11, pages 9225.
Crossref
Crossref
Nils Hillebrandt & Jürgen Hubbuch. (2023) Size-selective downstream processing of virus particles and non-enveloped virus-like particles. Frontiers in Bioengineering and Biotechnology 11.
Crossref
Crossref
Zhanzhuo Mai, Mengkai Cai, Xiaokun Hu, Meidi Li, Yikuan Ji, Shaofang Li, Junmei Huang, Quanming Liang, Chihai Ji, Heyou Yi, Guihong Zhang & Lang Gong. (2023) Protection efficacy of the H1 and H3 bivalent virus-like particle vaccine against swine influenza virus infection. Veterinary Microbiology 280, pages 109719.
Crossref
Crossref
Krystal A. Hughes, Bishal Misra, Maryam Maghareh & Sharan Bobbala. (2023) Use of stimulatory responsive soft nanoparticles for intracellular drug delivery. Nano Research 16:5, pages 6974-6990.
Crossref
Crossref
Miguel Angel Fuertes, Diego López Mateos, Luis Valiente, Alicia Rodríguez Huete, Alejandro Valbuena & Mauricio G. Mateu. (2023) Electrostatic Screening, Acidic pH and Macromolecular Crowding Increase the Self-Assembly Efficiency of the Minute Virus of Mice Capsid In Vitro. Viruses 15:5, pages 1054.
Crossref
Crossref
Mingyang Liu, Yan Zhao, Zhishang Shi, Jeffrey I. Zink & Qilin Yu. (2023) Virus-like Magnetic Mesoporous Silica Particles as a Universal Vaccination Platform against Pathogenic Infections. ACS Nano 17:7, pages 6899-6911.
Crossref
Crossref
Rushi Liu, Chufan Tan, Junwen Wu, Ye Xu, Xiaofeng Li, Zhihong Zhong, Sang Li, Yilan Qiu & Bo Feng. (2023) Characterization of genotype IV hepatitis E virus-like particles expressed in E.coli. Heliyon 9:4, pages e15284.
Crossref
Crossref
Sadhana Tripathi, Neelam Sharma, Leimarembi Devi Naorem & Gajendra P.S. Raghava. (2023) ViralVacDB: A manually curated repository of viral vaccines. Drug Discovery Today 28:4, pages 103523.
Crossref
Crossref
Cristina E. Martina, James E. CroweJr.Jr. & Jens Meiler. (2023) Glycan masking in vaccine design: Targets, immunogens and applications. Frontiers in Immunology 14.
Crossref
Crossref
Jinyang Li & Xinyue Li. (2023) Emerging role of vaccines in glioblastoma treatment. Highlights in Science, Engineering and Technology 36, pages 1544-1556.
Crossref
Crossref
Michael Kozak & Jiafen Hu. (2023) The Integrated Consideration of Vaccine Platforms, Adjuvants, and Delivery Routes for Successful Vaccine Development. Vaccines 11:3, pages 695.
Crossref
Crossref
Asta Lučiūnaitė, Indrė Dalgėdienė, Emilija Vasiliūnaitė, Milda Norkienė, Indrė Kučinskaitė-Kodzė, Aurelija Žvirblienė & Alma Gedvilaitė. (2023) Immunogenic Properties and Antigenic Similarity of Virus-like Particles Derived from Human Polyomaviruses. International Journal of Molecular Sciences 24:5, pages 4907.
Crossref
Crossref
Ting Wang, Lilan Zheng, Qiujian Zhao, Yazhou Yao, Feng Zhou, Fang Wei & Qiliang Cai. (2023) Parainfluenza virus 5 is a next‐generation vaccine vector for human infectious pathogens. Journal of Medical Virology 95:3.
Crossref
Crossref
Jort J. Altenburg, Maarten Klaverdijk, Damien Cabosart, Laurent Desmecht, Sonja S. Brunekreeft‐Terlouw, Joshua Both, Vivian I. P. Tegelbeckers, Marieke L. P. M. Willekens, Linda van Oosten, Tessy A. H. Hick, Tom M. H. van der Aalst, Gorben P. Pijlman, Monique M. van Oers, René H. Wijffels & Dirk E. Martens. (2022) Real‐time online monitoring of insect cell proliferation and baculovirus infection using digital differential holographic microscopy and machine learning. Biotechnology Progress 39:2.
Crossref
Crossref
Rebeca T. Stiepel, Eliza Duggan, Cole J. Batty & Kristy M. Ainslie. (2022) Micro and nanotechnologies: The little formulations that could. Bioengineering & Translational Medicine 8:2.
Crossref
Crossref
Mirosława Panasiuk, Milena Chraniuk, Karolina Zimmer, Lilit Hovhannisyan, Vasil Krapchev, Grażyna Peszyńska-Sularz, Magdalena Narajczyk, Jan Węsławski, Agnieszka Konopacka & Beata Gromadzka. (2023) Characterization of surface-exposed structural loops as insertion sites for foreign antigen delivery in calicivirus-derived VLP platform. Frontiers in Microbiology 14.
Crossref
Crossref
Reeshu Gupta, Kajal Arora, Sourav Singha Roy, Abyson Joseph, Ruchir Rastogi, Nupur Mehrotra Arora & Prabuddha K. Kundu. (2023) Platforms, advances, and technical challenges in virus-like particles-based vaccines. Frontiers in Immunology 14.
Crossref
Crossref
Haiyun Liu, Zhidong Teng, Hu Dong, Jiajun Li, Sahibzada Waheed Abdullah, Yun Zhang, Jinen Wu, Huichen Guo & Shiqi Sun. (2023) Poly(I:C) and CpG improve the assembly of foot-and-mouth disease virus-like particles and immune response in mice. Virology 579, pages 94-100.
Crossref
Crossref
Feng Xu, Ye Yuan, Ying Wang & Qiliang Yin. (2023) Emerging peptide-based nanovaccines: From design synthesis to defense against cancer and infection. Biomedicine & Pharmacotherapy 158, pages 114117.
Crossref
Crossref
Anastasiia S. Obozina, Elena N. Komedchikova, Olga A. Kolesnikova, Anna M. Iureva, Vera L. Kovalenko, Fedor A. Zavalko, Tatiana V. Rozhnikova, Ekaterina D. Tereshina, Elizaveta N. Mochalova & Victoria O. Shipunova. (2023) Genetically Encoded Self-Assembling Protein Nanoparticles for the Targeted Delivery In Vitro and In Vivo. Pharmaceutics 15:1, pages 231.
Crossref
Crossref
Zanair Soares Vasconcelos, Hany Abdulateif Salem, Sâmia Pimenta Veiga, Fabiola Estefany Botelho de Lima, César Rogério da Silva Gonçalves, Eliane Carvalho dos Santos, Alba Regina Jorge Brandão, Kátia Nascimento Couceiro, Jorge Augusto de Oliveira Guerra & Maria das Graças Vale Barbosa Guerra. (2023) Immunogenicity Characterization of COVID-19 Vaccines: A Systematic Review and Meta-analysis. Revista da Sociedade Brasileira de Medicina Tropical 56.
Crossref
Crossref
Hao-Yang Liu, Xiao Li, Zhi-Gang Wang & Shu-Lin Liu. (2023) Virus-mimicking nanosystems: from design to biomedical applications. Chemical Society Reviews.
Crossref
Crossref
Vahid Reza Askari, Roghayeh Yahyazadeh & Vafa Baradaran Rahimi. 2023. Viral Infections and Antiviral Therapies. Viral Infections and Antiviral Therapies
625
651
.
Ayşe Rüveyda Uğur & Mehmet Özdemir. 2023. Omics approaches and technologies in COVID-19. Omics approaches and technologies in COVID-19
389
404
.
Ali Rastegari, Homa Faghihi & Zohreh Mohammadi. 2023. Handbook of Biomolecules. Handbook of Biomolecules
439
466
.
James Michael Robinson, Phillip Louis Gomez III, Joseph A. Rogalewicz, Nicolas Havelange, Robert D. Sitrin & Regis Gervier. 2023. Plotkin's Vaccines. Plotkin's Vaccines
64
76
.
Ramalingam Karthik Raja, Phuong Nguyen-Tri, Govindasamy Balasubramani, Arun Alagarsamy, Selcuk Hazir, Safa Ladhari, Alireza Saidi, Arivalagan Pugazhendhi & Arulandhu Anthoni Samy. (2021) SARS-CoV-2 and its new variants: a comprehensive review on nanotechnological application insights into potential approaches. Applied Nanoscience 13:1, pages 65-93.
Crossref
Crossref
Ömür Baysal & Kubilay Kurtuluş Baştaş. 2023. Microbial Biocontrol: Molecular Perspective in Plant Disease Management. Microbial Biocontrol: Molecular Perspective in Plant Disease Management
187
203
.
S. Silpa, X. Janet Bertilla & S. Rupachandra. 2023. Protein-based Therapeutics. Protein-based Therapeutics
297
324
.
Milky Mittal, Adya Varshney, Nimisha Singh, Ashok Saini & Indra Mani. 2023. Biomanufacturing for Sustainable Production of Biomolecules. Biomanufacturing for Sustainable Production of Biomolecules
211
251
.
Sunil Kumar, Attuluri Vamsi Kumar & Hardeep Kaur. 2023. Nanovaccinology. Nanovaccinology
301
330
.
Shubhankhi Dey & Gajendra B. Singh. 2023. Nanovaccinology. Nanovaccinology
281
299
.
Abhilasha K. Rani, Wajihul Hasan Khan, Manidipa Banerjee & Anurag S. Rathore. 2023. Bioprocess and Analytics Development for Virus-based Advanced Therapeutics and Medicinal Products (ATMPs). Bioprocess and Analytics Development for Virus-based Advanced Therapeutics and Medicinal Products (ATMPs)
407
428
.
Abhilash Chiramel, Roland Pach & Saurabh Gautam. 2023. Bioprocess and Analytics Development for Virus-based Advanced Therapeutics and Medicinal Products (ATMPs). Bioprocess and Analytics Development for Virus-based Advanced Therapeutics and Medicinal Products (ATMPs)
1
17
.
Dimitris Tsakogiannis, Marios Nikolaidis, Flora Zagouri, Eleni Zografos, Christine Kottaridi, Zaharoula Kyriakopoulou, Lamprini Tzioga, Panayotis Markoulatos, Grigoris D. Amoutzias & Garyfalia Bletsa. (2022) Mutation Profile of HPV16 L1 and L2 Genes in Different Geographic Areas. Viruses 15:1, pages 141.
Crossref
Crossref
Enrico Palermo, Magdalini Alexandridi, Daniele Di Carlo, Michela Muscolini & John Hiscott. (2022) Virus-like particle – mediated delivery of the RIG-I agonist M8 induces a type I interferon response and protects cells against viral infection. Frontiers in Cellular and Infection Microbiology 12.
Crossref
Crossref
Jin Luo, Huan Qin, Lei Lei, Wange Lou, Ruitong Li & Zishu Pan. (2022) Virus-like particles containing a prefusion-stabilized F protein induce a balanced immune response and confer protection against respiratory syncytial virus infection in mice. Frontiers in Immunology 13.
Crossref
Crossref
Doddy Irawan Setyo Utomo, Sabar Pambudi & Enoch Y. Park. (2022) Humoral immune response induced with dengue virus-like particles serotypes 1 and 4 produced in silkworm. AMB Express 12:1.
Crossref
Crossref
Frédéric Tangy & Jean-Nicolas Tournier. (2022) Les virus au service de la santé : la vaccination. médecine/sciences 38:12, pages 1052-1060.
Crossref
Crossref
Yalini H. Wijesundara, Fabian C. Herbert, Sneha Kumari, Thomas Howlett, Shailendra Koirala, Orikeda Trashi, Ikeda Trashi, Noora M. Al-Kharji & Jeremiah J. Gassensmith. (2022) Rip it, stitch it, click it: A Chemist's guide to VLP manipulation. Virology 577, pages 105-123.
Crossref
Crossref
Yanli Yang, Ming Li, Yi Zhao, Xuan Lin, Zhiguo Su, Fei Xin, Xiaojie Du, Kan Zheng, Rui Han, Yiping Pan, Sun He & Songping Zhang. (2022) Mechanism and inhibition of abnormal chromatographic behavior of serotype type a inactivated foot and mouth disease virus in high-performance size-exclusion chromatography. Journal of Chromatography A 1686, pages 463648.
Crossref
Crossref
Jeong In Yang & Ki Hong Kim. (2022) Display of Streptococcus iniae α-Enolase on the Surface of Virus-Like Particles (VLPs) of Nervous Necrosis Virus (NNV) Using SpyTag/SpyCatcher. Marine Biotechnology 24:6, pages 1066-1072.
Crossref
Crossref
Ze-Hui Liu, Zhuo-Fan Deng, Ying Lu, Wei-Huan Fang & Fang He. (2022) A modular and self-adjuvanted multivalent vaccine platform based on porcine circovirus virus-like nanoparticles. Journal of Nanobiotechnology 20:1.
Crossref
Crossref
Sofia A. Martins, Joana Santos, Sandra Cabo Verde, João D. G. Correia & Rita Melo. (2022) Construction of HER2-Specific HIV-1-Based VLPs. Bioengineering 9:11, pages 713.
Crossref
Crossref
Dinh To Le, Marco T. Radukic, Kathrin Teschner, Lukas Becker & Kristian M. Müller. (2022)
Synthesis and Concomitant Assembly of Adeno-Associated Virus-like Particles in
Escherichia coli
. ACS Synthetic Biology 11:11, pages 3601-3607.
Crossref
Crossref
Rajashri Bezbaruah, Vivek P. Chavda, Lawandashisha Nongrang, Shahnaz Alom, Kangkan Deka, Tutumoni Kalita, Farak Ali, Bedanta Bhattacharjee & Lalitkumar Vora. (2022) Nanoparticle-Based Delivery Systems for Vaccines. Vaccines 10:11, pages 1946.
Crossref
Crossref
Audrey Olshefsky, Christian Richardson, Suzie H. Pun & Neil P. King. (2022) Engineering Self-Assembling Protein Nanoparticles for Therapeutic Delivery. Bioconjugate Chemistry 33:11, pages 2018-2034.
Crossref
Crossref
Youjun Mi, Lijuan Liang, Kun Xu, Qing Li, Wenting Wang, Wenrui Dang, Jiahui Deng, Yucheng Zhi, Xuefeng Li & Jiying Tan. (2022) Severe acute respiratory syndrome coronavirus 2 virus-like particles induce dendritic cell maturation and modulate T cell immunity. Frontiers in Cellular and Infection Microbiology 12.
Crossref
Crossref
Alexandre B. Murad, Marcos Q. Sousa, Ricardo Correia, Inês A. Isidro, Manuel J. T. Carrondo & António Roldão. (2022) Targeted Metabolic Analysis and MFA of Insect Cells Expressing Influenza HA-VLP. Processes 10:11, pages 2283.
Crossref
Crossref
Kaushal Jerajani, Ying Wan, John M. Hickey, Ozan S. Kumru, Nitya Sharma, Swathi R. Pullagurla, Oluwadara Ogun, Shweta Mapari, Neal Whitaker, Sarah Brendle, Neil D. Christensen, Saurabh Batwal, Mustafa Mahedvi, Harish Rao, Vikas Dogar, Rahul Chandrasekharan, Umesh Shaligram, Sangeeta B. Joshi & David B. Volkin. (2022) Analytical and Preformulation Characterization Studies of Human Papillomavirus Virus-Like Particles to Enable Quadrivalent Multi-Dose Vaccine Formulation Development. Journal of Pharmaceutical Sciences 111:11, pages 2983-2997.
Crossref
Crossref
Rahul Bhattacharjee, Ankit Kumar Dubey, Archisha Ganguly, Basudha Bhattacharya, Yogendra Kumar Mishra, Ebrahim Mostafavi & Ajeet Kaushik. (2022) State-of-art high-performance Nano-systems for mutated coronavirus infection management: From Lab to Clinic. OpenNano 8, pages 100078.
Crossref
Crossref
Robert Kinobe, Ageng Wiyatno, I. Made Artika & Dodi Safari. (2022) Insight into the Enterovirus A71: A review. Reviews in Medical Virology 32:6.
Crossref
Crossref
Leda R. Castilho, Nathalia R. Mattos, Wallace S. Abreu & Melissa L. E. Gutarra. (2022) Virus-like Particles (VLPs) as Important Tools for Flavivirus Vaccine Development. Biologics 2:4, pages 226-242.
Crossref
Crossref
Yong-Fei Zhou, Jiao-Jiao Nie, Chao Shi, Ke Ning, Yu-Feng Cao, Yanbo Xie, Hongyu Xiang & Qiuhong Xie. (2022) Expression and Immunogenicity of SARS-CoV-2 Virus-Like Particles based on Recombinant Truncated HEV-3 ORF2 Capsid Protein. Journal of Microbiology and Biotechnology 32:10, pages 1335-1343.
Crossref
Crossref
Srishti Chakravorty, Behdad Afzali & Majid Kazemian. (2022) EBV-associated diseases: Current therapeutics and emerging technologies. Frontiers in Immunology 13.
Crossref
Crossref
Paul Kato Kitandwe, Paul F. McKay, Pontiano Kaleebu & Robin J. Shattock. (2022) An Overview of Rift Valley Fever Vaccine Development Strategies. Vaccines 10:11, pages 1794.
Crossref
Crossref
Heribert Helgers, Alina Hengelbrock, Jamila Franca Rosengarten, Jörn Stitz, Axel Schmidt & Jochen Strube. (2022) Towards Autonomous Process Control—Digital Twin for HIV-Gag VLP Production in HEK293 Cells Using a Dynamic Metabolic Model. Processes 10:10, pages 2015.
Crossref
Crossref
Ruchika Yogesh, Noopur Srivastava & Syed Nasir Abbas Bukhari. (2022) COVID-19 Challenge: A Quest for Effective Vaccine Strategies Against Circulating
and Emerging SARS-CoV-2 Variants. Current Pharmaceutical Design 28:35, pages 2901-2913.
Crossref
Crossref
Viviana Pszenny, Erick Tjhin, Eliza V.C. Alves‐Ferreira, Stephanie Spada, Fadila Bouamr, Vinod Nair, Sundar Ganesan & Michael E. Grigg. (2022) Using the Sleeping Beauty (SB) Transposon to Generate Stable Cells Producing Enveloped Virus‐Like Particles (eVLPs) Pseudotyped with SARS‐CoV‐2 Proteins for Vaccination. Current Protocols 2:10.
Crossref
Crossref
Volkan Enes ERGÜDEN & Alper ÇİFTCİ. (2022) An Innovative Approach in The Field of Health: Nanoparticles/NanomedicineSağlık Alanında Yenilikçi Bir Yaklaşım: Nanopartiküller/Nanotıp. Journal of Anatolian Environmental and Animal Sciences 7:3, pages 304-313.
Crossref
Crossref
Chen-Wei Wang, Yung-Liang Chen, Simon J. T. Mao, Tzu-Chieh Lin, Ching-Wen Wu, Duangsuda Thongchan, Chi-Young Wang & Hung-Yi Wu. (2022) Pathogenicity of Avian Polyomaviruses and Prospect of Vaccine Development. Viruses 14:9, pages 2079.
Crossref
Crossref
Long Li & Guosong Chen. (2022) Precise Assembly of Proteins and Carbohydrates for Next-Generation Biomaterials. Journal of the American Chemical Society 144:36, pages 16232-16251.
Crossref
Crossref
Emils Bolmanis, Oskars Grigs, Andris Kazaks & Vytautas Galvanauskas. (2022) High-level production of recombinant HBcAg virus-like particles in a mathematically modelled P. pastoris GS115 Mut+ bioreactor process under controlled residual methanol concentration. Bioprocess and Biosystems Engineering 45:9, pages 1447-1463.
Crossref
Crossref
Manya Mittal, Manidipa Banerjee, Linda HL Lua & Anurag S Rathore. (2021) Current status and future challenges in transitioning to continuous bioprocessing of virus‐like particles. Journal of Chemical Technology & Biotechnology 97:9, pages 2376-2385.
Crossref
Crossref
Viol Dhea KharismaArif Nur Muhammad AnsoriVikash JakhmolaWahyu Choirur RizkyMuhammad Hermawan WidyanandaRasyadan Taufiq ProbojatiAhmad Affan Ali MurtadloMaksim RebezovPavel ScherbakovPavel BurkovYulia MatrosovaAlexander RomanovMaic Audo Eybi Mayer SihombingYulanda AntoniusRahadian Zainul. (2022) Multi-Strain Human Papillomavirus (HPV) Vaccine Innovation via Computational Study: A Mini Review. Research Journal of Pharmacy and Technology, pages 3802-3807.
Crossref
Crossref
Mona O. Mohsen & Martin F. Bachmann. (2022) Virus-like particle vaccinology, from bench to bedside. Cellular & Molecular Immunology 19:9, pages 993-1011.
Crossref
Crossref
Thomas C. Donahue, Guanghui Zong, Nicholas A. O’Brien, Chong Ou, Jeffrey C. Gildersleeve & Lai-Xi Wang. (2022) Synthesis and Immunological Study of N-Glycan-Bacteriophage Qβ Conjugates Reveal Dominant Antibody Responses to the Conserved Chitobiose Core. Bioconjugate Chemistry 33:7, pages 1350-1362.
Crossref
Crossref
Vasilis C. Pliasas, Zach Menne, Virginia Aida, Ji-Hang Yin, Maria C. Naskou, Peter J. Neasham, J. Fletcher North, Dylan Wilson, Katharine A. Horzmann, Joshy Jacob, Ioanna Skountzou & Constantinos S. Kyriakis. (2022) A Novel Neuraminidase Virus-Like Particle Vaccine Offers Protection Against Heterologous H3N2 Influenza Virus Infection in the Porcine Model. Frontiers in Immunology 13.
Crossref
Crossref
Cosette G. Schneider, Julien Fey, Xiaoyan Zou, Vince Gerbasi, Tatyana Savransky, Carl Batt, Elke Bergmann-Leitner & Evelina Angov. (2022) Norovirus-VLPs expressing pre-erythrocytic malaria antigens induce functional immunity against sporozoite infection. Vaccine 40:31, pages 4270-4280.
Crossref
Crossref
Ravi Bandaru, Smruti Rekha Rout, Omkar S. Kamble, Sangram K. Samal, Bapi Gorain, Amirhossein Sahebkar, Farhan J. Ahmed, Prashant Kesharwani & Rambabu Dandela. (2022) Clinical progress of therapeutics and vaccines: Rising hope against COVID-19 treatment. Process Biochemistry 118, pages 154-170.
Crossref
Crossref
Jyothy G. Vijayan. 2022. Nanovaccinology as Targeted Therapeutics. Nanovaccinology as Targeted Therapeutics
283
300
.
Tahmina Foyez & Abu Bin Imran. 2022. Nanovaccinology as Targeted Therapeutics. Nanovaccinology as Targeted Therapeutics
1
20
.
Bárbara Fernandes, Ricardo Correia, Paula M. Alves & António Roldão. (2022) Intensifying Continuous Production of Gag-HA VLPs at High Cell Density Using Stable Insect Cells Adapted to Low Culture Temperature. Frontiers in Bioengineering and Biotechnology 10.
Crossref
Crossref
Pooja Saxena. 2022. Bionanotechnology: Next-Generation Therapeutic Tools. Bionanotechnology: Next-Generation Therapeutic Tools
30
48
.
A. Shahrivarkevishahi, L.M. Hagge, O.R. Brohlin, S. Kumari, R. Ehrman, C. Benjamin & J.J. Gassensmith. (2022) Virus-like particles: a self-assembled toolbox for cancer therapy. Materials Today Chemistry 24, pages 100808.
Crossref
Crossref
Kimberly Braz Gomes, Grace Lovia Allotey-Babington, Sucheta D'Sa, Sang-Moo Kang & Martin J. D'Souza. (2022) Dendritic cell activation by a micro particulate based system containing the influenza matrix-2 protein virus-like particle (M2e VLP). International Journal of Pharmaceutics 622, pages 121667.
Crossref
Crossref
Ameneh Jafari, Fahima Danesh Pouya, Zahra Niknam, Meghdad Abdollahpour‑Alitappeh, Mostafa Rezaei-Tavirani & Yousef Rasmi. (2022) Current advances and challenges in COVID-19 vaccine development: from conventional vaccines to next-generation vaccine platforms. Molecular Biology Reports 49:6, pages 4943-4957.
Crossref
Crossref
Hui Yi Leong, Xiao‐Qian Fu, Pau Loke Show, Shan‐Jing Yao & Dong‐Qiang Lin. (2022) Downstream processing of virus‐like particles with aqueous two‐phase systems: Applications and challenges. Journal of Separation Science 45:12, pages 2064-2076.
Crossref
Crossref
Sisi Huang, Ray T. McClain & Richard Kenneth Marcus. (2022) Comparison of the separation of proteins of wide‐ranging molecular weight via trilobal polypropylene capillary‐channeled polymer fiber, commercial superficiously porous, and commercial size exclusion columns. Journal of Separation Science 45:9, pages 1502-1513.
Crossref
Crossref
Jesús Lavado‐García, Tao Zhang, Laura Cervera, Francesc Gòdia & Manfred Wuhrer. (2022)
Differential
N
‐ and
O
‐glycosylation signatures of HIV‐1 Gag virus‐like particles and coproduced extracellular vesicles
. Biotechnology and Bioengineering 119:5, pages 1207-1221.
Crossref
Crossref
Caroline Deshayes, Anne-Sophie Gosselin-Grenet, Mylène Ogliastro, Bruno Lapied & Véronique Apaire-Marchais. (2022) Can Virus-like Particles Be Used as Synergistic Agent in Pest Management?. Viruses 14:5, pages 943.
Crossref
Crossref
Iqra Mir, Sania Aamir, Syed Rizwan Hussain Shah, Muhammad Shahid, Iram Amin, Samia Afzal, Amjad Nawaz, Muhammad Umer Khan & Muhammad Idrees. (2022) Immune-related therapeutics: an update on antiviral drugs and vaccines to tackle the COVID-19 pandemic. Osong Public Health and Research Perspectives 13:2, pages 84-100.
Crossref
Crossref
Alina Hengelbrock, Heribert Helgers, Axel Schmidt, Florian Lukas Vetter, Alex Juckers, Jamila Franca Rosengarten, Jörn Stitz & Jochen Strube. (2022) Digital Twin for HIV-Gag VLP Production in HEK293 Cells. Processes 10:5, pages 866.
Crossref
Crossref
Beata Gromadzka, Milena Chraniuk, Lilit Hovhannisyan, Karolina Uranowska, Bogusław Szewczyk, Magdalena Narajczyk & Mirosława Panasiuk. (2022) Characterization of Immune Response towards Generation of Universal Anti-HA-Stalk Antibodies after Immunization of Broiler Hens with Triple H5N1/NA-HA-M1 VLPs. Viruses 14:4, pages 730.
Crossref
Crossref
Carlos U. Torres-Estrella, María del Rocío Reyes-Montes, Esperanza Duarte-Escalante, Mónica Sierra Martínez, María Guadalupe Frías-De-León & Gustavo Acosta-Altamirano. (2022) Vaccines Against COVID-19: A Review. Vaccines 10:3, pages 414.
Crossref
Crossref
Mengkai Cai, Ping Gan, Xiaokun Hu, Zhanzhuo Mai, Chihai Ji, Heyou Yi, Meidi Li, Shaofang Li, Yikuan Ji, Junmei Huang, Guihong Zhang & Lang Gong. (2022) Protective effect of bivalent H1N1 and H3N2 VLP vaccines against Eurasian avian-like H1N1 and recent human-like H3N2 influenza viruses in a mouse model. Veterinary Microbiology 266, pages 109370.
Crossref
Crossref
John Yu Cheng & Curtis E. Margo. (2022) Ocular adverse events following vaccination: overview and update. Survey of Ophthalmology 67:2, pages 293-306.
Crossref
Crossref
Md. Mijanur Rahman, Md. Habib Ullah Masum, Shah Wajed & Asma Talukder. (2022) A comprehensive review on COVID-19 vaccines: development, effectiveness, adverse effects, distribution and challenges. VirusDisease 33:1, pages 1-22.
Crossref
Crossref
Nawamin Sa-nguanmoo, Katawut Namdee, Mattaka Khongkow, Uracha Ruktanonchai, YongXiang Zhao & Xing-Jie Liang. (2021) Review: Development of SARS-CoV-2 immuno-enhanced COVID-19 vaccines with nano-platform. Nano Research 15:3, pages 2196-2225.
Crossref
Crossref
Heribert Helgers, Alina Hengelbrock, Axel Schmidt, Jamila Rosengarten, Jörn Stitz & Jochen Strube. (2022) Process Design and Optimization towards Digital Twins for HIV-Gag VLP Production in HEK293 Cells, including Purification. Processes 10:2, pages 419.
Crossref
Crossref
Reyad Almoheer, Mohd Effendy Abd Wahid, Hidayatul Aini Zakaria, Mohd Anuar Bin Jonet, Muhanna Mohammed Al-shaibani, Adel Al-Gheethi & Siti Nor Khadijah Addis. (2022) Spatial, Temporal, and Demographic Patterns in the Prevalence of Hemorrhagic Septicemia in 41 Countries in 2005–2019: A Systematic Analysis with Special Focus on the Potential Development of a New-Generation Vaccine. Vaccines 10:2, pages 315.
Crossref
Crossref
Anna Lucia Tornesello, Maria Tagliamonte, Franco M. Buonaguro, Maria Lina Tornesello & Luigi Buonaguro. (2022) Virus-like Particles as Preventive and Therapeutic Cancer Vaccines. Vaccines 10:2, pages 227.
Crossref
Crossref
Wattana Weerachatyanukul, Chettupon Pooljun, Ikuo Hirono, Hidehiro Kondo, Charoonroj Chotwiwatthanakun & Pitchanee Jariyapong. (2022) Infectious hypodermal and hematopoietic necrosis virus-like particle (IHHNV-VLP) induces peroxiredoxin expression and activity in Fenneropenaeus merguiensis. Fish & Shellfish Immunology 121, pages 53-61.
Crossref
Crossref
Saber Soltani, Milad Zandi, Parisa Shiri Aghbash, Masoud Rezaei, Nader Mohammadzadeh, Alireza Afsharifar & Vahdat Poortahmasebi. (2021) A review of COVID‐19 vaccines and major considerations for diabetic patients. Biotechnology and Applied Biochemistry 69:1, pages 30-40.
Crossref
Crossref
Limin Yang, Aibo Xiao, Hu Wang, Xiaojuan Zhang, Yuan Zhang, Yunlong Li, Yanqiu Wei, Wenjun Liu & Chuangfu Chen. (2022) A VLP-Based Vaccine Candidate Protects Mice against Japanese Encephalitis Virus Infection. Vaccines 10:2, pages 197.
Crossref
Crossref
Shalini Iyer, Rajesh Yadav, Smriti Agarwal, Shashank Tripathi & Rachit Agarwal. (2022) Bioengineering Strategies for Developing Vaccines against Respiratory Viral Diseases. Clinical Microbiology Reviews 35:1.
Crossref
Crossref
Hasnat Tariq, Sannia Batool, Saaim Asif, Mohammad Ali & Bilal Haider Abbasi. (2022) Virus-Like Particles: Revolutionary Platforms for Developing Vaccines Against Emerging Infectious Diseases. Frontiers in Microbiology 12.
Crossref
Crossref
Saifur Rehman, Fedik Abdul Rantam, Khadija Batool, Aamir Shehzad, Mustofa Helmi Effendi, Adiana Mutamsari Witaningrum, Muhammad Bilal & Muhammad Thohawi Elziyad Purnama. (2022) Emerging threats and vaccination strategies of H9N2 viruses in poultry in Indonesia: A review. F1000Research 11, pages 548.
Crossref
Crossref
Saifur Rehman, Fedik Abdul Rantam, Khadija Batool, Aamir Shehzad, Mustofa Helmi Effendi, Adiana Mutamsari Witaningrum, Muhammad Bilal & Muhammad Thohawi Elziyad Purnama. (2022) Emerging threat and vaccination strategies of H9N2 viruses in poultry in Indonesia: A review. F1000Research 11, pages 548.
Crossref
Crossref
Hitesh Kumar Dewangan & Suman Tomar. (2022) Nanovaccine for transdermal delivery system. Journal of Drug Delivery Science and Technology 67, pages 102988.
Crossref
Crossref
Izzat F.B.M Suffian & Khuloud T. Al-Jamal. (2022) Bioengineering of virus-like particles as dynamic nanocarriers for in vivo delivery and targeting to solid tumours. Advanced Drug Delivery Reviews 180, pages 114030.
Crossref
Crossref
Kenneth Lundstrom. 2022. mRNA-Based Therapeutics. mRNA-Based Therapeutics
97
157
.
Samira S. Abolmaali, Vahid Alimardani, Ghazal Farahavar, Haniyeh Najafi, Mina Shafiee, Nader Tanideh, Ali M. Tamaddon & Samad Ahadian. 2022. Emerging Nanomaterials and Nano-Based Drug Delivery Approaches to Combat Antimicrobial Resistance. Emerging Nanomaterials and Nano-Based Drug Delivery Approaches to Combat Antimicrobial Resistance
305
364
.
Maryam Tabarzad, Elham Mohit & Fatemeh Ghorbani-Bidkorbeh. 2022. Emerging Nanomaterials and Nano-Based Drug Delivery Approaches to Combat Antimicrobial Resistance. Emerging Nanomaterials and Nano-Based Drug Delivery Approaches to Combat Antimicrobial Resistance
425
484
.
Young Chan Kim & Arturo Reyes-Sandoval. 2022. Biomedical Innovations to Combat COVID-19. Biomedical Innovations to Combat COVID-19
115
127
.
Salvador F. Ausar, Nicholas R. Larson, Yangjie Wei, Akshay Jain & C. Russell Middaugh. 2022. Practical Aspects of Vaccine Development. Practical Aspects of Vaccine Development
79
135
.
Farshad Hemmati, Mohsen Hemmati-Dinarvand, Marziye Karimzade, Daria Rutkowska, Mohammad Hadi Eskandari, Sayyad Khanizadeh & Alireza Afsharifar. (2021) Plant-derived VLP: a worthy platform to produce vaccine against SARS-CoV-2. Biotechnology Letters 44:1, pages 45-57.
Crossref
Crossref
Ernesto Garay, Diego Fontana, Lautaro Leschiutta, Ricardo Kratje & Claudio Prieto. (2021) Rational design of novel fusion rabies glycoproteins displaying a major antigenic site of foot-and-mouth disease virus for vaccine applications. Applied Microbiology and Biotechnology 106:2, pages 579-592.
Crossref
Crossref
Abhijeet Nayak. 2022. Microbial Engineering for Therapeutics. Microbial Engineering for Therapeutics
163
200
.
Farrhana Ziana Firdaus, Mariusz Skwarczynski & Istvan Toth. 2022. Vaccine Design. Vaccine Design
145
178
.
Prashamsa Koirala, Sahra Bashiri, Istvan Toth & Mariusz Skwarczynski. 2022. Vaccine Design. Vaccine Design
309
338
.
Timothy M. Caradonna & Aaron G. Schmidt. (2021) Protein engineering strategies for rational immunogen design. npj Vaccines 6:1.
Crossref
Crossref
Majed Ghattas, Garima Dwivedi, Marc Lavertu & Mohamad-Gabriel Alameh. (2021) Vaccine Technologies and Platforms for Infectious Diseases: Current Progress, Challenges, and Opportunities. Vaccines 9:12, pages 1490.
Crossref
Crossref
Mirosława Panasiuk, Karolina Zimmer, Anna Czarnota, Katarzyna Grzyb, Magdalena Narajczyk, Grażyna Peszyńska-Sularz, Sabina Żołędowska, Dawid Nidzworski, Lilit Hovhannisyan & Beata Gromadzka. (2021) Immunization with Leishmania tarentolae-derived norovirus virus-like particles elicits high humoral response and stimulates the production of neutralizing antibodies. Microbial Cell Factories 20:1.
Crossref
Crossref
Eliane Marti, Ella N. Novotny, Iva Cvitas, Anja Ziegler, A. Douglas Wilson, Sigurbjörg Torsteinsdottir, Antonia Fettelschoss‐Gabriel & Sigridur Jonsdottir. (2021)
Immunopathogenesis and immunotherapy of
Culicoides
hypersensitivity in horses: an update
. Veterinary Dermatology 32:6, pages 579.
Crossref
Crossref
Chandran Murugan, Sharmiladevi Ramamoorthy, Guruprasad Kuppuswamy, Rajesh Kumar Murugan, Yuvaraj Sivalingam & Anandhakumar Sundaramurthy. (2021) COVID-19: A review of newly formed viral clades, pathophysiology, therapeutic strategies and current vaccination tasks. International Journal of Biological Macromolecules 193, pages 1165-1200.
Crossref
Crossref
Guanghui Zong, Christian Toonstra, Qiang Yang, Roushu Zhang & Lai-Xi Wang. (2021) Chemoenzymatic Synthesis and Antibody Binding of HIV-1 V1/V2 Glycopeptide-Bacteriophage Qβ Conjugates as a Vaccine Candidate. International Journal of Molecular Sciences 22:22, pages 12538.
Crossref
Crossref
Jimmy Gaudreault, Catherine Forest-Nault, Gregory De Crescenzo, Yves Durocher & Olivier Henry. (2021) On the Use of Surface Plasmon Resonance-Based Biosensors for Advanced Bioprocess Monitoring. Processes 9:11, pages 1996.
Crossref
Crossref
Thaissa Consoni Bernardino, Renato Mancini Astray, Carlos Augusto Pereira, Vera Lucia Boldorini, Marta Maria Antoniazzi, Simone Gonçalves Silva Jared, Eutimio Gustavo Fernández Núñez & Soraia Attie Calil Jorge. (2021) Production of Rabies VLPs in Insect Cells by Two Monocistronic Baculoviruses Approach. Molecular Biotechnology 63:11, pages 1068-1080.
Crossref
Crossref
Eunjung Kim, Eun‐Kyung Lim, Geunseon Park, Chaewon Park, Jong‐Woo Lim, Hyo Lee, Woonsung Na, Minjoo Yeom, Jinyoung Kim, Daesub Song & Seungjoo Haam. (2021) Advanced Nanomaterials for Preparedness Against (Re‐)Emerging Viral Diseases. Advanced Materials 33:47.
Crossref
Crossref
Jing Miao, Peng Gao, Qian Li, Kaifeng He, Liwen Zhang, Junyan Wang & Lingfei Huang. (2021) Advances in Nanoparticle Drug Delivery Systems for Anti-Hepatitis B Virus Therapy: A Narrative Review. International Journal of Molecular Sciences 22:20, pages 11227.
Crossref
Crossref
Kenneth Lundstrom. (2021) Self-Replicating RNA Viruses for Vaccine Development against Infectious Diseases and Cancer. Vaccines 9:10, pages 1187.
Crossref
Crossref
Ming-Hao Yang, Chung-Chi Hu, Chi-Hzeng Wong, Jian-Jong Liang, Hui-Ying Ko, Meng-Hsun He, Yi-Ling Lin, Na-Sheng Lin & Yau-Heiu Hsu. (2021) Convenient Auto-Processing Vector Based on Bamboo Mosaic Virus for Presentation of Antigens Through Enzymatic Coupling. Frontiers in Immunology 12.
Crossref
Crossref
Hengyu Liu, Wenhao Zhong, Xinyu Zhang, Dongjun Lin & Jun Wu. (2021) Nanomedicine as a promising strategy for the theranostics of infectious diseases. Journal of Materials Chemistry B 9:38, pages 7878-7908.
Crossref
Crossref
Gefei Li, Wenxiao Ma, Juan Mo, Boyang Cheng, Shin-ichiro Shoda, Demin Zhou & Xin-Shan Ye. (2021) Influenza Virus Precision Diagnosis and Continuous Purification Enabled by Neuraminidase-Resistant Glycopolymer-Coated Microbeads. ACS Applied Materials & Interfaces 13:39, pages 46260-46269.
Crossref
Crossref
Shruthi Polla Ravi, Yasmeen Shamiya, Aishik Chakraborty, Cynthia Elias & Arghya Paul. (2021) Biomaterials, biological molecules, and polymers in developing vaccines. Trends in Pharmacological Sciences 42:10, pages 813-828.
Crossref
Crossref
Saurabh Shah, Mahavir Bhupal Chougule, Arun K. Kotha, Rama Kashikar, Chandraiah Godugu, Rajeev Singh Raghuvanshi, Shashi Bala Singh & Saurabh Srivastava. (2021) Nanomedicine based approaches for combating viral infections. Journal of Controlled Release 338, pages 80-104.
Crossref
Crossref
Simon Staubach, Fabiola Nardi Bauer, Tobias Tertel, Verena Börger, Oumaima Stambouli, Denise Salzig & Bernd Giebel. (2021) Scaled preparation of extracellular vesicles from conditioned media. Advanced Drug Delivery Reviews 177, pages 113940.
Crossref
Crossref
Xuan Zhang, Yan Zhang, Haiping Zheng, Yufeng He, Honglin Jia, Liyuan Zhang, Chunjie Lin, Shuang Chen, Junfeng Zheng, Qunfang Yang, Tao Liu, Xichun Pan, Haigang Zhang, Chenhui Wang, Lei Ren & Wenjun Shan. (2021) In Situ biomimetic Nanoformulation for metastatic cancer immunotherapy. Acta Biomaterialia 134, pages 633-648.
Crossref
Crossref
Tamara G. Dacoba, Shubaash Anthiya, Germán Berrecoso, Iago Fernández‐Mariño, Carmen Fernández‐Varela, José Crecente‐Campo, Desirée Teijeiro‐Osorio, Fernando Torres Andón & María J. Alonso. (2021) Nano‐Oncologicals: A Tortoise Trail Reaching New Avenues. Advanced Functional Materials 31:44.
Crossref
Crossref
Lu Su, Yingle Feng, Kongchang Wei, Xuyang Xu, Rongying Liu & Guosong Chen. (2021) Carbohydrate-Based Macromolecular Biomaterials. Chemical Reviews 121:18, pages 10950-11029.
Crossref
Crossref
Puna Maya Maharjan & Sunghwa Choe. (2021) Plant-Based COVID-19 Vaccines: Current Status, Design, and Development Strategies of Candidate Vaccines. Vaccines 9:9, pages 992.
Crossref
Crossref
Seok-Jin Kang, Sung-Min Bae, Hye-Jeong Lee, Young-Ju Jeong, Min-A Lee, Su-Hwa You, Hyang-Sim Lee, Bang-Hun Hyun, Nakhyung Lee & Sang-Ho Cha. (2021) Porcine Circovirus (PCV) Genotype 2d-Based Virus-like Particles (VLPs) Induced Broad Cross-Neutralizing Antibodies against Diverse Genotypes and Provided Protection in Dual-Challenge Infection of a PCV2d Virus and a Type 1 Porcine Reproductive and Respiratory Syndrome Virus (PRRSV). Pathogens 10:9, pages 1145.
Crossref
Crossref
Michael Taynnan Barros, Mladen Veletic, Masamitsu Kanada, Massimiliano Pierobon, Seppo Vainio, Ilangko Balasingham & Sasitharan Balasubramaniam. (2021) Molecular Communications in Viral Infections Research: Modeling, Experimental Data, and Future Directions. IEEE Transactions on Molecular, Biological and Multi-Scale Communications 7:3, pages 121-141.
Crossref
Crossref
Mengnan Guo, Jiajun Li, Zhidong Teng, Mei Ren, Hu Dong, Yun Zhang, Jiaxi Ru, Ping Du, Shiqi Sun & Huichen Guo. (2021) Four Simple Biomimetic Mineralization Methods to Improve the Thermostability and Immunogenicity of Virus-like Particles as a Vaccine against Foot-and-Mouth Disease. Vaccines 9:8, pages 891.
Crossref
Crossref
Madhusudan Rajendran, Florian Krammer & Meagan McMahon. (2021) The Human Antibody Response to the Influenza Virus Neuraminidase Following Infection or Vaccination. Vaccines 9:8, pages 846.
Crossref
Crossref
Shi‐Jian Song, Gyeong‐Im Shin, Jinyong Noh, Jiho Lee, Deok‐Hwan Kim, Gyeongryul Ryu, Gyeongik Ahn, Hyungmin Jeon, Hai‐Ping Diao, Youngmin Park, Min Gab Kim, Woe‐Yeon Kim, Young‐Jin Kim, Eun‐Ju Sohn, Chang Seon Song & Inhwan Hwang. (2021)
Plant‐based, adjuvant‐free, potent multivalent vaccines for avian influenza virus via
Lactococcus
surface display
. Journal of Integrative Plant Biology 63:8, pages 1505-1520.
Crossref
Crossref
Natsuki Kurokawa, Pierre-Olivier Lavoie, Marc-André D'Aoust, Manon M.-J. Couture, Michèle Dargis, Sonia Trépanier, Shigeki Hoshino, Tomohiro Koike, Masaaki Arai & Naohisa Tsutsui. (2021) Development and characterization of a plant-derived rotavirus-like particle vaccine. Vaccine 39:35, pages 4979-4987.
Crossref
Crossref
Anne-Catherine Fluckiger, Barthelemy Ontsouka, Jasminka Bozic, Abebaw Diress, Tanvir Ahmed, Tamara Berthoud, Anh Tran, Diane Duque, Mingmin Liao, Michael McCluskie, Francisco Diaz-Mitoma, David E. Anderson & Catalina Soare. (2021) An enveloped virus-like particle vaccine expressing a stabilized prefusion form of the SARS-CoV-2 spike protein elicits highly potent immunity. Vaccine 39:35, pages 4988-5001.
Crossref
Crossref
Akbar Hasanzadeh, Masoomeh Alamdaran, Sepideh Ahmadi, Helena Nourizadeh, Mohammad Aref Bagherzadeh, Mirza Ali Mofazzal Jahromi, Perikles Simon, Mahdi Karimi & Michael R. Hamblin. (2021) Nanotechnology against COVID-19: Immunization, diagnostic and therapeutic studies. Journal of Controlled Release 336, pages 354-374.
Crossref
Crossref
Zhongyuan Guo, Luke J. Kubiatowicz, Ronnie H. Fang & Liangfang Zhang. (2021) Nanotoxoids: Biomimetic Nanoparticle Vaccines against Infections. Advanced Therapeutics 4:8.
Crossref
Crossref
Gizem Ölçücü, Oliver Klaus, Karl-Erich Jaeger, Thomas Drepper & Ulrich Krauss. (2021)
Emerging Solutions for
in Vivo
Biocatalyst Immobilization: Tailor-Made Catalysts for Industrial Biocatalysis
. ACS Sustainable Chemistry & Engineering 9:27, pages 8919-8945.
Crossref
Crossref
Mohamed H. El-Husseiny, Naglaa M. Hagag, Peter Pushko, Irina Tretyakova, Mahmoud M. Naguib & Abdel Satar Arafa. (2021) Evaluation of Protective Efficacy of Influenza Virus Like Particles Prepared from H5N1 Virus of Clade 2.2.1.2 in Chickens. Vaccines 9:7, pages 715.
Crossref
Crossref
Jun Li, Rumeng Li, Qi Zhang, Peipei Peng, Xiaoquan Wang, Min Gu, Zenglei Hu, Xinan Jiao, Daxin Peng, Jiao Hu & Xiufan Liu. (2021) H7N9 influenza virus-like particle based on BEVS protects chickens from lethal challenge with highly pathogenic H7N9 avian influenza virus. Veterinary Microbiology 258, pages 109106.
Crossref
Crossref
Ziyan Wang, Chenliang Zhou, Fan Gao, Qianjun Zhu, Yuanxiang Jiang, Xinxing Ma, Yalin Hu, Likang Shi, Xiaoliang Wang, Chao Zhang, Baofeng Liu, Lianzhong Shen, Qunying Mao & Ge Liu. (2021) Preclinical evaluation of recombinant HFMD vaccine based on enterovirus 71 (EV71) virus-like particles (VLP): Immunogenicity, efficacy and toxicology. Vaccine 39:31, pages 4296-4305.
Crossref
Crossref
Displaying 200 of 612 citing articles. Use the download link below to view the full list of citing articles.
Download full citations list